Journal of Clinical Psychopharmacology

Article	Citations
Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder	32
Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia	32
Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior	29
Persistent Barriers to the Use of Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia	29
Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers	28
A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder	28
Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs	27
Citalopram and Cannabidiol	26
Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis	23
Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder	23
European Whites May Need Lower Minimum Therapeutic Clozapine Doses Than Those Customarily Proposed	20
Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults	20
Comparison of Rapid Antidepressant and Antisuicidal Effects of Intramuscular Ketamine, Oral Ketamine, and Electroconvulsive Therapy in Patients With Major Depressive Disorder	20
Effect of Valproic Acid on the Metabolic Spectrum of Clozapine in Patients With Schizophrenia	18
The Modernization of Clozapine	17
A Systematic Review on the Efficacy of Intravenous Racemic Ketamine for Bipolar Depression	16
COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants—A Scoping Review	15
Clozapine Response in Schizophrenia and Hematological Changes	15
Clozapine-Associated Myocarditis	15
Implementation and Outcomes of a Clozapine-Associated Myocarditis Screening Program in a Region of South Australia—Lessons Learned	15
Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users	14
A Seizure After COVID-19 Vaccination in a Patient on Clozapine	14
Combined Oxytocin and Cognitive Behavioral Social Skills Training for Social Function in People With Schizophrenia	13
Clozapine	13
Cannabidiol as a Treatment for Mental Health Outcomes Among Health Care Workers During the Coronavirus Disease Pandemic	12

Escaping the Long Shadow Cast by Agranulocytosis	12
Successful Clozapine Rechallenge After Suspected Clozapine-Associated Myocarditis	12
A Chart Audit Study of Clozapine Utilization in Early Psychosis	12
Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070)	12
Adjunctive Raloxifene and Isradipine Improve Cognitive Functioning in Patients With Schizophrenia	12
A New Treatment Paradigm	11
Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative Users	11
Nanocurcumin as an Add-on to Antipsychotic Drugs for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia	11
Ketamine and Monoamine Oxidase Inhibitor Combination	11
One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia	10
Vortioxetine on Cognition in Schizophrenia	10
Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients	10
Comparison of the Metabolic Characteristics of Newer Second Generation Antipsychotics	10
All in One	10
Risk of Nonalcoholic Fatty Liver Disease in Patients With Schizophrenia Treated With Antipsychotic Drugs	10
Free Testosterone and Prolactin Levels and Sperm Morphology and Function Among Male Patients With Tramadol Abuse	10
Binge Eating Disorders in Antipsychotic-Treated Patients With Schizophrenia	10
An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention	10
Reproductive Safety of Trazodone After Maternal Exposure in Early Pregnancy	10
Risk of Depression Associated With Finasteride Treatment	10
Use of Benzodiazepines and Antipsychotic Drugs Are Inversely Associated With Acute Readmission Risk in Schizophrenia	9
Dry Those Crying Eyes	9
Special Article: Translational Science Update. Pharmacological Implications of Emerging Schizophrenia Genetics	9
Prevalence and Appropriateness of Antipsychotic Prescribing in an Italian Prison	9
The Effect of Therapeutic Alliance on Attitudes Toward Psychiatric Medications in Schizophrenia	9
Safety and Efficacy in Randomized Controlled Trials of Second-Generation Antipsychotics Versus Placebo for Cognitive Impairments in Schizophrenia	9
The Concurrent Treatment With Intravenous Ketamine and an Irreversible Monoamine Oxidase Inhibitor for Treatment-Resistant Depression Without Hypertensive Crises	9
Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults	8
Effect of Ketamine on Rumination in Treatment-Resistant Depressive Patients	8
Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts	8
Comparative Efficacy and Tolerability of Antipsychotics for Juvenile Psychotic Disorders	8
A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants	8
Dose-Dependent Inhibition of CYP2D6 by Bupropion in Patients With Depression	8
Evaluation of Emotional Adverse Effects of Antidepressants	8
Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder	8
α-Lipoic Acid as Adjunctive Treatment for Schizophrenia	8
Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets	8
Esketamine	8
The Use of Methylphenidate for Cognitive Enhancement in Young Healthy Adults	8
Domestic Mass Shooters	8
Effect of Brexpiprazole on Prolactin and Sexual Functioning	8
Effects of Bedtime Dosing With Suvorexant and Zolpidem on Balance and Psychomotor Performance in Healthy Elderly Participants During the Night and in the Morning	8
Antipsychotic-Associated Weight Gain and Clinical Improvement Under Clozapine Treatment	7
Model-Based Approach for Establishing the Predicted Clinical Response of a Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder	7
Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine–Assisted Therapy for Posttraumatic Stress Disorder	7
The Pitfalls of Psychotropic Polypharmacy	7
Prolactin and Estrogen Levels in Postmenopausal Women Receiving Aripiprazole Augmentation Treatment for Depression	7
Quetiapine in the Anxiety Dimension of Mood Disorders	7
Clozapine Blood Concentration Predicts Corrected QT-Interval Prolongation in Patients With Psychoses	7
The Effect of Venlafaxine on Electrocardiogram Intervals During Treatment for Depression in Older Adults	7

Tolerability of High-Dose Venlafaxine After Switch From Escitalopram in Nonresponding Patients With Major Depressive Disorder	7
Clozapine Once-Daily Versus Divided Dosing Regimen	7
Drug-Associated Liver Injury Related to Antipsychotics	7
Antidepressants and Risk of Type 2 Diabetes Mellitus	7
Antidepressant Augmentation	7
Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects	7
Real-World Clinical Practice Among Patients With Bipolar Disorder and Chronic Kidney Disease on Long-term Lithium Therapy	7
Elevated Clozapine Blood Concentrations After Second COVID-19 Vaccination With Spikevax (COVID-19 Vaccine Moderna)	7
Methamphetamine-Associated Hyperammonemic Encephalopathy	7
Melancholic Features in Bipolar Depression and Response to Lamotrigine	7
A Single-Blind Randomized Comparison of Lithium and Lamotrigine as Maintenance Treatments for Managing Bipolar II Disorder	6
Association of Optimal Lamotrigine Serum Levels and Therapeutic Efficacy in Mood Disorders	6
Psychosis Treatment During COVID-19 Pandemic and the Potential Role of Phenothiazines	6
Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics	6
Recurrence of Mania or Depression Among Adult Bipolar Patients Who Continued Using Lithium	6
Successful Management of Methylphenidate or Atomoxetine-Related Priapism During Attention-Deficit Hyperactivity Disorder Treatment	6
Ambulatory Heart Rate Variability in Schizophrenia or Depression	6
A Case of Treatment-Refractory Hyperemesis Gravidarum Responsive to Adjunctive Mirtazapine in a Patient With Anxiety Comorbidity and Severe Weight Loss	6
Influence of Different Antidepressants on Ocular Surface in Patients With Major Depressive Disorder	6
Antipsychotic Medication in Sub-Saharan Africa	6
Prescribing Tamoxifen in Patients With Mood Disorders	6
A Real-World Study of Risk Factors for QTc Prolongation in Schizophrenia Patients Receiving Atypical Antipsychotics	6
Food and Drug Administration–Approved Treatments for Acute Bipolar Depression	6
Paliperidone-Associated Sialorrhea	6
Guideline Adherence of Monitoring Antipsychotic Use for Nonpsychotic Indications in Children and Adolescents	6
Homeopathic Remedies in Psychiatric Disorders	6
Effects of Oxytocin on Emotion Recognition in Schizophrenia	6
Opioid Receptor μ-1 and Ketamine Effects in a Suicidal Depression Trial	6
Pramipexole to Improve Cognition in Bipolar Disorder	6
High-Dose Fluvoxamine Augmentation to Clozapine in Treatment-Resistant Psychosis	6
Effects of Dose, Age, Sex, Body Weight, and Smoking on Plasma Concentrations of Olanzapine and N-desmethyl Olanzapine in Inpatients With Schizophrenia	6
A Potential Drug-Gene-Drug Interaction Between Cannabidiol, CYP2D6*4, and Fluoxetine	6
Major Adverse Cardiovascular Events in Antidepressant Users Within Patients With Ischemic Heart Diseases	6
Adverse Effects After Ayahuasca Administration in the Clinical Setting	6
Pharmacotherapy Prescriptions for Relapse Prevention of Psychotic Depression After Electroconvulsive Therapy	5
Lisdexamfetamine-Associated Tonsure Trichotillomania	5
Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia	5
Efficacy of Vortioxetine Monotherapy for Posttraumatic Stress Disorder	5
Esketamine for Unipolar Major Depression With Psychotic Features	5
How Frequent Is Switching From an Initial Stimulant Family to the Alternative One in the Clinical Setting?	5
Sublingual Oxytocin With Clozapine in a Patient With Persisting Psychotic Symptoms, Suicidal Thinking With Self-Harm	5
Prebiotic Treatment Increases Serum Butyrate in People With Schizophrenia	5
Effect of Exenatide Use on Cognitive and Affective Functioning in Obese Patients With Type 2 Diabetes Mellitus	5
Craving Moderates the Effects of Intranasal Oxytocin on Anger in Response to Social Stress Among Veterans With Co-Occurring Posttraumatic Stress Disorder and Alcohol Use Disorder	5
Diazepam in the Elderly: Looking Back, Ahead, and at the Evidence	5
A Double-Blind, Placebo-Controlled Trial of Bupropion Add-on to Olanzapine or Risperidone in Overweight Individuals With Schizophrenia	5
Valproic Acid–Associated Hyperammonemia	5
Cost of the Illness of Treatment-Resistant Schizophrenia	5
A Preliminary Examination of Endogenous Peripheral Oxytocin in a Pilot Randomized Clinical Trial of Oxytocin-Enhanced Psychotherapy for Posttraumatic Stress Disorder	5
Anti-inflammatory Combination Therapy for the Treatment of Schizophrenia	5
Antipsychotic-Related Fatal Poisoning, England and Wales, 1993–2019	5
Association of Antidepressant Continuation in Pregnancy and Infant Birth Weight	5
No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder	5
The Effect of Clozapine on Self-reported Duration of Sleep and Its Interaction With 23 Other Medications	5
A Decrease of Neutrophils After COVID-19 Vaccination in a Treatment-Resistant Patient With Schizophrenia Taking Clozapine	4
The Effects of Nicotine on Cortical Excitability After Exercise	4
General Functioning in Patients With First-Episode Psychosis After the First 18 Months of Treatment	4
Valproate-Associated Hyperammonemic Encephalopathy	4
Combination With Long-Acting Injectable Antipsychotics and Utilization of Nonstandard Formulations as Compliance Enhancing Methods for Clozapine Users	4
Structured Interventions to Optimize Polypharmacy in Psychiatric Treatment and Nursing Homes	4
Augmentation With Pimavanserin in Treatment Refractory Schizophrenia	4
Improvements of Frontotemporal Cerebral Blood Flow and Cognitive Functioning in Patients With First Episode of Schizophrenia Treated With Long-Acting Aripiprazole	4
Case Report	4
Olanzapine-Related Somnambulism	4
Antidepressant Discontinuation	4
Genetic Analysis of Clozapine Metabolism in a Patient With Subtherapeutic Clozapine Plasma Concentrations—The Importance of CYP3A5	4
Low-dose Quetiapine for Major Depressive Disorder and Sleep Improvement	4
Trazodone as an Alternative Treatment for Neuroleptic-Associated Akathisia	4
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants	4
Tolterodine in the Treatment of Clozapine-Associated Urinary Incontinence	4
Adjunctive Fluvoxamine for Schizophrenia: A Meta-analysis of Randomized Double-Blind, Placebo-Controlled Trials	4
Rhabdomyolysis With Clozapine and Haloperidol Coadministration	4
Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination	4
Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive Dyskinesia	4
Central Nervous System Trial Failures	4
A Withdrawal Syndrome After a Switch of Phenibut to Another γ-Aminobutyric Acid Agonist	4
Association Between CYP2D6 Metabolizer Status and Vortioxetine Exposure and Treatment Switching	4
Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents	4
Clozapine and Oral Contraceptives—Implications Beyond Pharmacokinetics	4
Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative Users	4

Hypertensive Emergency and Stroke With Medication Interaction	4
Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D2 Receptor Occupancy	4
The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly	4
Successful Introduction of Paliperidone Palmitate for Pregnant Woman With Schizophrenia	4
Effects of Oral Administration of Alprazolam and Lorazepam as Hypnotics on Cardiovascular Parameters in Hypertensive Patients	4
Lurasidone Augmentation of Clozapine in Refractory Schizophrenia	4
Sertraline-Associated Burning Mouth Syndrome	4
Case Reports	3
Covert Dyskinesia With Aripiprazole	3
Metabolite Profiling of Clozapine in Patients Switching Versus Maintaining Treatment	3
Polaprezinc (Zinc–l-Carnosine Complex) as an Add-on Therapy for Binge Eating Disorder and Bulimia Nervosa, and the Possible Involvement of Zinc Deficiency in These Conditions	3
Antipsychotics and Drug-Induced Liver Injury	3
How to Estimate QT Interval in Patients With Left or Right Bundle Branch Block	3
Calcium Channel Antagonists for Mood Disorders	3
Raising the Quality of Psychopharmacology Clinical Psychiatric Practice	3
Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reu	3
Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series	3
Use of Sublingual Atropine Drops in Clozapine-Associated Sialorrhea in an Adolescent Patient	3
Topiramate (1000 mg) Abuse for Weight Loss in an Adolescent With Anorexia Nervosa	3
Safety of Use of Clozapine in Patients With Schizophrenia With Comorbid Diabetes Mellitus	3
Treatment of Clozapine-Associated Sialorrhea	3
Exceptionally High Clozapine-Associated Eosinophilia	3
Use of Suvorexant and Antipsychotics in the Treatment of Delirium After Infectious Diseases	3
Abilify MyCite (Aripiprazole)	3
Why Is There No Food and Drug Administration–Approved Medication for Major Depression With Psychotic Features?	3
Should Antipsychotic Medications Be Prescribed to Patients With Nonpsychotic Depression?	3
Physostigmine for Facilitation of Care in Clozapine-Associated Anticholinergic Delirium	3
Catatonia and Delirium	3
Hematological and Other Cancers in People Using Clozapine	3
Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia	3
Risk of Prolonged Corrected QT Interval With Amisulpride Therapy for Renal Function Management in Patients With Schizophrenia	3
Prescription Stimulants and the Risk of Psychosis	3
Are the Same Medications that Are Used in the Acute Treatment of Depression the Most Suitable for Preventing Relapse?	3
Novel Use of Clozapine for Nonsuicidal Self-Injury in Adolescent Treatment-Resistant Depression	3
The Effects of a Gluten-Free Diet on Immune Markers and Kynurenic Acid Pathway Metabolites in Patients With Schizophrenia Positive for Antigliadin Antibodies Immunoglobulin G	3
CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12–17 Years, Wi	3
Pharmacotherapy of Substance Use Disorders	3
A Manic Episode With Psychotic Features Associated With Levetiracetam	3
Intravenous Augmentative Valproate Versus Delorazepam in Bipolar Patients With a Major Depressive Mixed Episode and Partial/Nonresponse to Oral Treatment	3
Switching to Intranasal Esketamine Maintains the Antidepressant Response to Intravenous Racemic Ketamine Administration	3
Toxidrome of an Easily Obtainable Nootropic	3
Treatment of Opioid Use Disorder Attributed to Fentanyl With High-Dose Buprenorphine	3
Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia	3
Valbenazine Treatment of Tardive Dyskinesia and of Positive Symptoms	3
Black Hairy Tongue Associated With Olanzapine Use in a Female Dementia Patient	3
Burning Mouth Syndrome	3
Effects of Vortioxetine Versus Placebo on Cognition and Functional Capacity in Adults With Posttraumatic Stress Disorder	3
Quetiapine-Associated Rhabdomyolysis	3
Monoamine Oxidase Interactions	3
Effect of Cigarette Smoking on Clozapine Dose and on Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice	3
Risperidone-Associated Acute Laryngeal Dystonia	3
Time to Reconsider Monoamine Oxidase Inhibitors for Obsessive Compulsive Disorder? A Case Series Using Phenelzine	3
Switch to 3-Month Long-Acting Injectable Paliperidone May Decrease Plasma Levels	3
Is Sitagliptin Effective for Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients? A Double-blind Placebo-controlled Clinical Trial	3
Acute Aripiprazole-Associated Liver Injury	3
Pharmacokinetics of Ketamine Transfer Into Human Milk	3
Mononitrate Isosorbide as an Adjunctive Therapy in Schizophrenia	3
Lamotrigine-Associated Hemophagocytic Lymphohistiocytosis	3
Risk of Major Malformations Following First-Trimester Exposure to Olanzapine	3
Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers	3